The COVID-19 pandemic has generated an overuse of antimicrobials in critically ill patients.
Acinetobacter baumannii frequently causes nosocomial infections, particularly in intensive …

Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with
hospital-acquired infections. The recent increase in incidence, largely associated with …

Acinetobacter baumannii has emerged as a medically important pathogen because of the
increasing number of infections produced by this organism over the preceding three …

Acinetobacter baumannii has emerged as a highly troublesome pathogen for many
institutions globally. As a consequence of its immense ability to acquire or upregulate …

Acinetobacter baumannii is one of the major pathogenic ESKAPE bacterium, which is
responsible for about more than 722,000 cases in a year, globally. Despite the alarming …

Since the 1970s, the spread of multidrug-resistant (MDR) Acinetobacter strains among
critically ill, hospitalized patients, and subsequent epidemics, have become an increasing …

Acinetobacter is a complex genus, and historically, there has been confusion about the
existence of multiple species. The species commonly cause nosocomial infections …

The gram-negative coccobacillus acinetobacter, a pathogen once seen only in hot, humid
climates, has become an increasingly common nosocomial problem even in temperate …

Members of the genus Acinetobacter have been implicated in a wide spectrum of infectious
diseases. Although this organism is associated primarily with nosocomial infections, it has …

Acinetobacter baumannii is a pathogen of increasing medical importance with a propensity
to be multidrug resistant, thereby making treatment challenging. Little is known of virulence …